Document Detail

Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.
MedLine Citation:
PMID:  3137397     Owner:  NLM     Status:  MEDLINE    
We studied production of, absorption of and response to interleukin 2 (IL-2) by peripheral blood mononuclear cells (PBMC) from 66 patients with gynecologic malignancies, in addition to measurement of the OKT 4/OKT 8 cell ratio. Patients with benign tumor served as controls. The OKT 4/OKT 8 cell ratio in patients with advanced (but not early) gynecologic malignancies was significantly lower than that in patients with benign tumor. PBMC from advanced cancer patients activated with phytohemagglutinin (PHA) had significantly lower IL-2 production compared to that from patients with benign tumors, while significant changes in their ability to respond to IL-2 and to absorb IL-2 were not observed. Absolute numbers of OKT 8 positive cells in PBMC of patients with good prognosis were significantly decreased after surgery and chemotherapy, while those of OKT 4 positive cells remained unchanged. Although IL-2 production in PBMC of patients with good prognosis was significantly elevated after chemotherapy, that in PBMC of patients with poor prognosis declined to about a half of pre-operative levels. The ability of PBMC to respond to IL-2 was significantly elevated not only in patients with good prognosis but also in patients with poor prognosis after termination of chemotherapy. On the other hand, the ability of PBMC to absorb IL-2 remained unchanged during the course of treatment. These findings may contribute to the understanding of tumor-induced immune suppression.
Y Kikuchi; T Kita; K Oomori; M Miyauchi; I Iwano; I Kizawa
Related Documents :
1654197 - Analysis of beta, gamma, and delta t-cell receptor genes in mycosis fungoides and sezar...
2091987 - Effect of chemotherapy on cell counts in peripheral blood & bronchoalveolar lavage of p...
11890987 - Replication status in leukocytes of treated and untreated patients with polycythemia ve...
1150277 - Gm(1) and gm(2) immunoglobulin allotypes in patients with malignant melanoma.
2561997 - Cns cryptococcosis: unusual aspects.
12924527 - Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical oncology and tumor pharmacotherapy     Volume:  5     ISSN:  0736-0118     ISO Abbreviation:  Med Oncol Tumor Pharmacother     Publication Date:  1988  
Date Detail:
Created Date:  1988-10-04     Completed Date:  1988-10-04     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8405039     Medline TA:  Med Oncol Tumor Pharmacother     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  85-90     Citation Subset:  IM    
Department of Obstetrics and Gynecology, National Defense Medical College, Saitama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, Surface / analysis
Genital Neoplasms, Female / blood*
Interleukin-2 / analysis*
Leukocytes, Mononuclear / analysis*
Lymphocyte Activation
Middle Aged
Ovarian Neoplasms / blood,  secondary
Receptors, Immunologic / analysis
Receptors, Interleukin-2
Uterine Cervical Neoplasms / blood
Uterine Neoplasms / blood
Reg. No./Substance:
0/Antigens, Surface; 0/Interleukin-2; 0/Receptors, Immunologic; 0/Receptors, Interleukin-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mass screening for breast cancer: benefits, risks, costs.
Next Document:  Differentiation of human leukaemic cell lines and fresh leukaemia cells by low dose Ara-C: monitorin...